Keck Graduate Institute (窪蹋勛圖厙) has received $1.5 million from Amgen, one of the worlds leading biotechnology companies, to start a two-year masters degree program that responds to the tremendous progress in genetic medicine and growing demand for professionals trained in both genetics and counseling.
The 窪蹋勛圖厙 Master of Science in Human Genetics and Genetic Counseling program is expected to enroll its first students in the 20182019 academic year.
Believed to be the only masters degree of its kind in the United States housed within a school of pharmacy, the 窪蹋勛圖厙 program will become one of 34 nationally and only the fourth in California. Unlike existing programs, which average eight students in size, the 窪蹋勛圖厙 M.S. in Human Genetics and Genetic Counseling is expected to enroll at least 24 students, expanding educational opportunities for qualified applicants. This larger number is made possible by the Amgen gift as well as 窪蹋勛圖厙s extensive network of industry and healthcare partners providing students with greater access to clinical rotations and training in other settings, including genetic testing service and bioscience companies.
The 窪蹋勛圖厙 program will also be distinguished by a curriculum that incorporates study of drug and diagnostic development, data analytics and pharmacogeneticsthe genetic basis of variability in drug responsein addition to topics such as the principles of human genetics, human developmental biology, and medical communication. The program will feature 窪蹋勛圖厙s characteristic hands-on, team-based approach to learning; clinical rotations at leading medical centers in California and elsewhere in the country; and an independent research thesis guided by advisors drawn from 窪蹋勛圖厙s faculty as well as healthcare and industry partners.
Historically, graduates with this degree have focused more on the counseling than the drug research and development aspects of the profession, 窪蹋勛圖厙 President Sheldon M. Schuster said. At 窪蹋勛圖厙, we want to prepare students for a variety of professional settings and train scientists to participate more fully in the drug development process. We are deeply grateful to be supported in this effort by Amgen, which has once again demonstrated its strong commitment to 窪蹋勛圖厙 and our contributions to education, research and industry.
窪蹋勛圖厙s Amgen Bioprocessing Center, which develops innovative educational training for students and others in the region, was established in 2004 through a generous donation from the Amgen Foundation, the main philanthropic arm of the company. Amgen leaders have also come to 窪蹋勛圖厙 for industry talks and other presentations, including the 2016 commencement ceremony in which Amgens chairman and chief executive officer, Robert A. Bradway, served as the keynote speaker.
We are pleased to support 窪蹋勛圖厙 in establishing the new Human Genetics and Genetic Counseling Degree Program, Bradway said. Amgen is deeply committed to utilizing tools like advanced human genetics to understand the complexities of disease, as well as partnering with leading institutions such as 窪蹋勛圖厙 to meet the demand for professionals in this critical and rapidly expanding arena.
Preparation to enroll the first students in the new 窪蹋勛圖厙 program has already begun. The process to gain accreditation for the program by three key organizationsthe American Board of Genetic Counseling, Accreditation Council for Genetic Counseling and Western Association of Schools and Colleges (WASC)is underway, as is the search for a program director, which 窪蹋勛圖厙 expects to hire within the next month.